Other substances

Procyanidin B2

A flavonoid.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

Supporting references

Contradictory references

AI-suggested references

Clinical trials

General information

Procyanidin B2 on PubChem

Synonyms

Proanthocyanidin B2

Structure image - Procyanidin B2

C1[C@H]([C@H](OC2=C1C(=CC(=C2[C@@H]3[C@H]([C@H](OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)O)O)O)C6=CC(=C(C=C6)O)O)O

Supporting references

Link	Tested on	Impact factor	Notes	Publication date
Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study 3CLpro PapainLpro RdRpol Small molecule In silico	in silico	3.22	Predicted to inhibit SARS-CoV-2 3C-like protease.	Mar/10/2021

AI-suggested references

Link	Publication date
Transcription factor NF-kappaB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model.	Jun/23/2021
Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study	Jul/29/2021
Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2	Nov/30/2020
Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections	Jul/08/2021
Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat's Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling	Feb/14/2022